Published in J Neurol on October 01, 1992
Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infect Immun (1995) 1.00
IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol (1994) 0.92
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature (1999) 8.50
Yeast cells lacking 5'-->3' exoribonuclease 1 contain mRNA species that are poly(A) deficient and partially lack the 5' cap structure. Mol Cell Biol (1993) 6.36
An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature (1996) 6.15
Monitoring clinical trials--interim data should be publicly available. BMJ (2001) 4.20
PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy. JAMA (1998) 3.94
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
Glutathione, oxidative stress and neurodegeneration. Eur J Biochem (2000) 3.11
Complete genome sequence of Vibrio fischeri: a symbiotic bacterium with pathogenic congeners. Proc Natl Acad Sci U S A (2005) 3.05
Pyoderma gangrenosum and its treatment. Lancet (1997) 2.83
Cholesterol and Alzheimer's disease: is there a link? Neurology (2001) 2.79
New small polypeptides associated with DNA-dependent RNA polymerase of Escherichia coli after infection with bacteriophage T4. Proc Natl Acad Sci U S A (1972) 2.75
The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology (1996) 2.74
Purification and characterization of a Saccharomyces cerevisiae exoribonuclease which yields 5'-mononucleotides by a 5' leads to 3' mode of hydrolysis. J Biol Chem (1980) 2.71
Disruption of the gene XRN1, coding for a 5'----3' exoribonuclease, restricts yeast cell growth. Gene (1990) 2.33
Cerebellar encephalitis in adults. J Neurol (1993) 2.30
Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res (2001) 2.26
A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol (2000) 2.21
An essential yeast gene with homology to the exonuclease-encoding XRN1/KEM1 gene also encodes a protein with exoribonuclease activity. Mol Cell Biol (1993) 2.20
Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes. EMBO J (1997) 2.18
Prospective health impact assessment: pitfalls, problems, and possible ways forward. BMJ (2001) 2.15
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart (2008) 2.03
Differential effects of central verses peripheral vision on egocentric and exocentric motion perception. Exp Brain Res (1973) 1.98
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer (2007) 1.84
Saccharomyces cerevisiae RAI1 (YGL246c) is homologous to human DOM3Z and encodes a protein that binds the nuclear exoribonuclease Rat1p. Mol Cell Biol (2000) 1.82
Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem (2000) 1.78
Health care needs assessment in prisons: a toolkit. J Public Health Med (2001) 1.73
Visual control of arm movement in Parkinson's disease. Mov Disord (1994) 1.69
A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology (1995) 1.65
Monitoring mRNA decapping activity. Methods (1999) 1.64
Moving visual scenes influence the apparent direction of gravity. Science (1972) 1.62
Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology (2002) 1.60
If the NHS introduced a '50 procedures a year' policy, what proportion of consultant firms would be affected? J Public Health Med (2001) 1.59
Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol (1984) 1.57
A 5'----3' exoribonuclease of Saccharomyces cerevisiae: size and novel substrate specificity. Arch Biochem Biophys (1987) 1.57
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet (2000) 1.54
Quantitative analysis of stance in late cortical cerebellar atrophy of the anterior lobe and other forms of cerebellar ataxia. Brain (1979) 1.51
Deoxyribonucleic acid dependent ribonucleic acid polymerases from two T4 phage-infected systems. Biochemistry (1974) 1.51
The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol (1998) 1.50
Treatment of cutaneous larva migrans. N Engl J Med (1998) 1.49
The significance of proprioception on postural stabilization as assessed by ischemia. Brain Res (1984) 1.48
Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand (1998) 1.46
Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression Project. Br J Psychiatry (2001) 1.46
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Repellent signaling by Slit requires the leucine-rich repeats. J Neurosci (2001) 1.45
CNS involvement in hereditary neuropathy with pressure palsies (HNPP). Neurology (2006) 1.44
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol (1999) 1.44
Cerebellar ataxia in ataxic hemiparesis? A kinematic and EMG analysis. Mov Disord (1993) 1.43
Mechanisms underlying recovery of eye-head coordination following bilateral labyrinthectomy in monkeys. Exp Brain Res (1973) 1.42
Treatment of cutaneous leishmaniasis with oral itraconazole. Int J Dermatol (1994) 1.42
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
Work practices and histopathological changes in the tenosynovium and flexor retinaculum in carpal tunnel syndrome in women. J Bone Joint Surg Br (1999) 1.41
Commentary on drug-eluting stents: NICE technology appraisal guidance. Heart (2008) 1.41
Judging outcomes in psychosocial interventions for dementia caregivers: the problem of treatment implementation. Gerontologist (2001) 1.40
Distortions in judged spatial relations. Cogn Psychol (1978) 1.39
The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. Health Technol Assess (2007) 1.39
[Neuronal protection in neurologic diseases?]. Nervenarzt (1994) 1.38
Manifestation of Hashimoto's encephalopathy years before onset of thyroid disease. Eur Neurol (1999) 1.36
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
Potential use of routine databases in health technology assessment. Health Technol Assess (2005) 1.35
The aetiology of sporadic adult-onset ataxia. Brain (2002) 1.34
Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun (1999) 1.33
On the role of vestibular, visual and somatosensory information for dynamic postural control in humans. Prog Brain Res (1988) 1.31
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain (2001) 1.30
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry (1999) 1.29
The development toward stereotypic arm kinematics during reaching in the first 3 years of life. Exp Brain Res (1997) 1.29
Day case surgery trends in England: the influences of target setting and of general practitioner fundholding. J Health Serv Res Policy (1998) 1.29
Identifying 'non-medical' datasets to monitor community health and well-being. J Public Health Med (2001) 1.29
Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive system of transgenic mice. Am J Physiol (1998) 1.28
An exoribonuclease from Saccharomyces cerevisiae: effect of modifications of 5' end groups on the hydrolysis of substrates to 5' mononucleotides. Biochem Biophys Res Commun (1978) 1.27
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene (2000) 1.26
Early stabilization of human posture after a sudden disturbance: influence of rate and amplitude of displacement. Exp Brain Res (1984) 1.25
Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer (1998) 1.25
TREATMENT OF DUODENAL ULCER BY CONSERVATIVE GASTRIC RESECTION WITH PARTIAL VAGOTOMY. Calif Med (1948) 1.25
A defect of kinesthesia in Parkinson's disease. Mov Disord (1995) 1.23
Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain (1998) 1.23
Characterization of an inhibitor causing potassium chloride sensitivity of an RNA polymerase from T4 phage-infected Escherichia coli. Biochemistry (1975) 1.22
Variability of postural "reflexes" in humans. Exp Brain Res (1983) 1.22
Some methods and parameters of body sway quantification and their neurological applications. Arch Psychiatr Nervenkr (1970) (1980) 1.22
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol (1999) 1.21
The effect of lateral head tilt on horizontal postrotatory nystagmus I and II and the Purkinje effect. Acta Otolaryngol (1985) 1.20
The development of goal-directed reaching in infants: hand trajectory formation and joint torque control. Exp Brain Res (1995) 1.20
Randomisation in trials: do potential trial participants understand it and find it acceptable? J Med Ethics (2004) 1.19
Classical conditioning after cerebellar lesions in humans. Behav Neurosci (1993) 1.19
Characteristic alterations of long-loop "reflexes" in patients with Friedreich's disease and late atrophy of the cerebellar anterior lobe. J Neurol Neurosurg Psychiatry (1984) 1.19
A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J Clin Invest (1988) 1.19
Motion habituation: inverted self-motion perception and optokinetic after-nystagmus. Exp Brain Res (1974) 1.19
Structural modifications of RNA influence the 5' exoribonucleolytic hydrolysis by XRN1 and HKE1 of Saccharomyces cerevisiae. Biochem Biophys Res Commun (1997) 1.18
Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache (1991) 1.18
Functional coupling of human cortical sensorimotor areas during bimanual skill acquisition. Brain (1999) 1.18
Gluteal compartment syndrome due to rhabdomyolysis after heroin abuse. Neurology (1997) 1.17
The origin of contraversive pushing: evidence for a second graviceptive system in humans. Neurology (2000) 1.14
Use of health services by prison inmates: comparisons with the community. J Epidemiol Community Health (2001) 1.13